Pravastatin for prevention of HELLP syndrome: A case report.
Medicine (Baltimore)
; 96(42): e8229, 2017 Oct.
Article
em En
| MEDLINE
| ID: mdl-29049209
ABSTRACT
RATIONALE Pravastatin has emerged for prevention and treatment of preeclampsia; no reports are available on pravastatin and HELLP (hemolysis, elevated liver enzymes and low platelets) syndrome. PATIENT CONCERNS The first pregnancy necessitated termination of pregnancy at gestational age (GA) 20+5 for HELLP. Intrauterine fetal death at GA 22+5 occurred in the second pregnancy, whilst on temporizing management of HELLP. DIAGNOSES Severe, recurrent early-onset HELLP syndrome. INTERVENTIONS:
In her fourth pregnancy, pravastatin was commenced at GA 13.OUTCOMES:
The course of pregnancy was uncomplicated, and a healthy, appropriate for gestational age fetus was delivered at term. LESSONS Pravastatin may be effective in prevention of HELLP. The hepatic uptake may be of particular advantage.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Pravastatina
/
Síndrome HELLP
/
Inibidores de Hidroximetilglutaril-CoA Redutases
Limite:
Adult
/
Female
/
Humans
/
Pregnancy
Idioma:
En
Revista:
Medicine (Baltimore)
Ano de publicação:
2017
Tipo de documento:
Article
País de afiliação:
Alemanha